医学
2019年冠状病毒病(COVID-19)
2019-20冠状病毒爆发
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
梅德林
家庭医学
大流行
冠状病毒感染
医学教育
病毒学
内科学
疾病
传染病(医学专业)
爆发
政治学
法学
作者
Roy M. Gulick,Alice K. Pau,Eric S. Daar,Laura Evans,Rajesh T. Gandhi,Pablo Tebas,Renée Ridzon,Henry Masur,H. Clifford Lane,Adaora A. Adimora,Jason Baker,Lisa Baumann Kreuziger,Roger Bedimo,Pamela S. Belperio,Anoopindar Bhalla,Timothy Burgess,Danielle Campbell,Stephen V. Cantrill,Kara W Chew,Kathleen Chiotos
标识
DOI:10.7326/annals-24-00464
摘要
The purpose of this article is to expand on the experiences of the NIH COVID-19 Treatment Guidelines Panel (the Panel) over the past 4 years, summarize the Panel's final recommendations for COVID-19, highlight some challenges and unanswered questions about COVID-19 management, and inform future responses to public health emergencies. The Panel was formed in March 2020, and the first iteration of the guidelines was released in April 2020. Now that the public health emergency has ended, the NIH COVID-19 Treatment Guidelines have sunsetted. This role will now fall to professional societies and organizations, such as the American College of Physicians, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the World Health Organization, all of which have been active in this area.
科研通智能强力驱动
Strongly Powered by AbleSci AI